ARCHIVES

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

New Treatment Projects Get Go-Ahead; Groups Competition To Be Increased, VA Studies Face Cut

November 4, 1977

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014